Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Aesthet Surg J. 2021 Oct 15;41(11):1338. doi: 10.1093/asj/sjab111.
No abstract available

Publication types

  • Published Erratum